Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model

BACKGROUND: Oligomeric forms of amyloid-β (Aβ) and tau are increasing being recognized as key toxins in the pathogenesis of Alzheimer’s disease (AD). METHODS: We developed a novel monoclonal antibody (mAb), GW-23B7, that recognizes β-sheet secondary structure on pathological oligomers of neurodegene...

Descripción completa

Detalles Bibliográficos
Autores principales: Goñi, Fernando, Martá-Ariza, Mitchell, Herline, Krystal, Peyser, Daniel, Boutajangout, Allal, Mehta, Pankaj, Drummond, Eleanor, Prelli, Frances, Wisniewski, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789573/
https://www.ncbi.nlm.nih.gov/pubmed/29378642
http://dx.doi.org/10.1186/s13195-018-0337-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789573/
https://www.ncbi.nlm.nih.gov/pubmed/29378642
http://dx.doi.org/10.1186/s13195-018-0337-3

Ejemplares similares